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Two laboratory mutants of NDM-1 were generated by replacing the isoleucine at position 35 with threonine and serine residues:
the NDM-1I35T and NDM-1I35S enzymes. These mutants were well characterized, and their kinetic parameters were compared
with those of the NDM-1 wild type. The kcat,Km, and kcat/Km values calculated for the twomutants were slightly different from
those of the wild-type enzyme. Interestingly, the kcat/Km of NDM-1
I35S for loracarbef was about 14-fold higher than that of
NDM-1. Far-UV circular dichroism (CD) spectra of NDM-1 and NDM-1I35T and NDM-1I35S enzymes suggest local structural
rearrangements in the secondary structure with a marked reduction of -helix content in the mutants.
The NDM-1 metallo--lactamase (MBL) was first described ina urinary Klebsiella pneumoniae isolate recovered from a
Swedish patient who traveled to New Delhi and who had received
medical care in India (1). This is the most recent MBL to have
widely spread around the world among enterobacterial strains,
Pseudomonas aeruginosa (2), Acinetobacter baumannii (3), Mor-
ganella morganii (4), Alcaligenes faecalis, Vibrio cholerae, and
Stenotrophomonas maltophilia (5, 6). NDM-1-producing bacteria
have been recovered from many infection sites as hospital-ac-
quired and community-acquired infections but also in environ-
mental samples (7). Since its finding, 12 NDM variants have been
identified (http://www.lahey.org/Studies/). The factor that has in-
fluenced the wide geographic spread of blaNDM-1 gene is its local-
ization on complex plasmids that mediate the transfer of this re-
sistant determinant under the selective pressure of antibiotic
therapy (8, 9).Metallo--lactamases show a broad-spectrum sub-
strate profile; they are resistant to classical -lactamase inhibitors
and hydrolyze carbapenems very efficiently. MBLs require one or
two zinc ions to catalyze the hydrolysis of -lactams. It is com-
monly suggested that the zinc ion acts as a Lewis acid to stabilize
the transient tetrahedral intermediate formed by the nucleophilic
attachment of a hydroxide ion to the carboxyl group of the -lac-
tam ring (10). NDM-1 enzyme shows a great ability to hydrolyze
all -lactam antibiotics (11). Several crystal structures of NDM-1
have been solved, and the enzyme displays the typical / fold
of MBLs (12, 13, 14). NDM-1 belongs to subclass B1, and it con-
tains a binuclear Zn active site surrounded by several loops re-
sponsible for substrate binding and specificity (13). Several studies
pointed out the attention focused on the L3 loop, which could be
involved in the hydrophobic contacts with substrates through the
presence of an aromatic residue. Moreover, its great flexibility
makes the loop able to drive substrate into the active site. The role
of the L3 loop has been studied in such subclass B1MBLs as IMP-1
and VIM-2 (15), but no experimental data are available for the
NDM-1 enzyme. In comparison to the IMP and VIM variants,
NDM-1 has a longer N terminus which forms two extra strands
that pack on the L3 loop through an isoleucine residue at position
35 (BBL numbering). Thus, the role of this loop in the NDM-1
enzyme could be related to the influence of isoleucine 35 (I35). In
fact, as previously reported, the I35 in NDM-1 is positioned at the
tip of the1 strand and seems to play an important role both in the
extension of the hydrophobicity of the L3 loop and in the substrate
binding and specificity (13). In order to elucidate the importance
of residue 35, a nonpolar residue of isoleucine in this position was
replaced by two polar residues, serine (S) and threonine (T). In
particular, our aimwas to understand how I35 could influence the
permanence of the hydrophobicity of the L3 loop and substrate
binding and if it perturbs the enzyme structure.
(Part of this study was presented at the 12th -Lactamase
Meeting, June 28 to July 1 2014, Gran Canaria, Canary Islands,
Spain.)
MATERIALS AND METHODS
Mutant design. NDM-1I35T and NDM-1I35S mutants were generated by
site-directed mutagenesis using the overlap extension method (16). Each
mutation was introduced into a PCR amplicon using mutagenic primers
in combination with external primers NDM_for and NDM_rev (Table 1)
and pFM-NDM-1 plasmid as the template. Two partially overlapping
DNA fragments generated by PCR were subsequently used in an overlap
extension reaction coupled to amplification of the entire coding sequence
with external primers. Each fragment was sequenced using an ABI Prism
310 single-capillary automated sequencer (Life Technologies, Monza,
Italy).
Cloning of blaNDM-1, blaNDM-1
I35T, and blaNDM-1
I35S determinants.
Genes blaNDM-1 (wild type), blaNDM-1
I35T, and blaNDM-1
I35S were cloned
with and without signal peptide in pET-24(a) vector using the NdeI and
XhoI restriction sites to obtain plasmids pSP-NDM-1, pSP-NDM-1I35T,
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and pSP-NDM-1I35S (with signal peptide) and pFM-NDM-1, pFM-
NDM-1I35T, and pFM-NDM-1I35S (without signal peptide). Escherichia
coli NovaBlue strain was used as a nonexpression host for the initial
cloning. The recombinant plasmids were then transferred into E. coli
JM109(DE3) for enzyme expression. The authenticity of cloned mutant
genes was verified by sequencing both strands of the three recombinant
plasmids using a single-capillary automated sequencer (ABI Prism 310;
Life Technologies, Italy).
Antimicrobial susceptibility tests. The phenotypic profile has been
characterized by a microdilution method using a bacterial inoculum of
5 105 CFU/ml according to Clinical and Laboratory Standards Institute
(CLSI) performance standards (17). Nitrocefin was kindly provided by
Shariar Mobashery (Notre Dame University, South Bend, IN, USA).
Meropenemwas fromAstraZeneca (Milan, Italy). Imipenem, ertapenem,
and cefoxitin were fromMerck Sharp & Dohme (Rome, Italy). Biapenem
was from Cyanamid (Catania, Italy). Loracarbef and cefaclor were from
Eli Lilly and Co. (Indianapolis, IN, USA). Ceftazidime was from Glaxo-
SmithKline (Verona, Italy). Biapenemwas fromWyeth-Lederle (Catania,
Italy). The other antimicrobial agents used in this study were purchased
from Sigma-Aldrich (Milan, Italy).
Expression andpurificationofNDM-1,NDM-1I35T, andNDM-1I35S
enzymes. E. coli JM109(DE3) cells containing the recombinant plasmids
pFM-NDM-1, pFM-NDM-1I35T, and pFM-NDM-1I35S were grown in 1
liter of tryptic soy broth (TSB) medium with kanamycin (50 g/ml) at
37°C in an orbital shaker (180 rpm). Each culture was grown to achieve an
A600 of approximately 0.5, and 0.4 mM IPTG (isopropyl--D-thiogalac-
topyranoside) was added. After addition of IPTG, the cultures were incu-
bated for 16 h at 22°C, under aerobic conditions. Cells were harvested by
centrifugation at 8,000 rpm for 10 min at 4°C and washed twice with 20
mM Tris-HCl buffer (pH 7.0) (buffer A). Crude enzymes were obtained
by treatment with lysozyme at a concentration of 2 mg/ml for 30 min at
30°C following by sonication on ice (5 cycles at 60W for 1 min and 2 min
of break). The lysate was centrifuged at 30,000 rpm for 30 min, and the
cleared supernatant was recovered and loaded onto a Sepharose-Q fast-
flow column equilibrated with buffer A. The column was extensively
washed to remove unboundproteins, and the-lactamasewas elutedwith
a linear gradient of 20 mM Tris-HCl (pH 7.0)–NaCl (0.5 M) (buffer B).
The fractions containing -lactamase activity were pooled, concentrated
20-fold using an Amicon concentrator (YM 10 membrane; Millipore,
Bedford, MA, USA), and loaded onto Sephacryl S-100 equilibrated with
buffer A. The pure fractions were pooled and dialyzed in 20 mM HEPES
buffer (pH 7.0) containing 0.01 mg/ml bovine serum albumin (BSA)
(buffer C) for further experiments.
Electrophoretic analysis and protein determination. Sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed by following the method of Laemmli (18) with a fixed 12.5%
(wt/vol) polyacrylamide gel in the presence of 0.1% SDS, using a Mini-
Protean III apparatus (Bio-Rad Laboratories, Richmond, CA). After elec-
trophoresis, the proteins bandswere stainedwithCoomassie brilliant blue
R-250. TheMr value was determined by comparison of its relative mobil-
ity with that of a standard protein mixture. Protein content was deter-
mined by the Bradford method with bovine serum albumin as the stan-
dard (19).
Determination of kinetic parameters. -Lactamase activity was rou-
tinely measured by spectrophotometric assay following the hydrolysis of
100 M imipenem. One unit of -lactamase activity was defined as the
amount of enzyme which hydrolyzes 1mol of substrate per min at 25°C
in buffer C, containing 0.01 mg/ml of BSA (bovine serum albumin) for
enzyme stability.
Steady-state kinetic experiments were performed following the hydro-
lysis of 16 -lactams (data not shown) at 25°C in buffer C plus 20 M
ZnCl2. The data were collected with a Perkin-Elmer Lambda 25 spectro-
photometer (Perkin-Elmer Italia, Monza, Italy). Kinetic parameters were
determined under initial-rate conditions using GraphPad Prism6 soft-
ware to generate Michaelis-Menten curves or by analyzing the complete
hydrolysis time courses (20, 21). Each kinetic value represents themean of
the results of five different measurements; the error rate was below 5%.
The effect of zinc content on NDM-1, NDM-1I35T, and NDM-1I35S
activity was evaluated by following the hydrolysis of 100 M imipenem
using concentrations of ZnCl2 ranging from 0 M to 100 M. The initial
hydrolysis rate (v0) was expressed inmillimoles perminute permilligram.
The volumeof the reactionmixturewas 1ml. The effect of temperature on
enzyme stability was evaluated by measuring the residual activity of the
enzymes versus that seenwith 100Mimipenem at 30°C, 40°C, and 50°C.
The enzymes were incubated for up to 120 min in buffer C.
Fluorescence spectroscopy. Fluorescence spectra of the purified en-
zymes (200 nM in buffer C) at 20°C were recorded in the 300-to-460-nm
range following excitation at 280 nm, using a Perkin-Elmer LS50B fluo-
rescence spectrometer (Perkin-Elmer,Monza, Italy) and a scan rate of 200
nm min1. Excitation and emission slit widths were both 5 nm. Spectra
were recorded five times, the results were averaged, and the fluorescence
background of the buffer was subtracted.
CD. Far-UV circular dichroism (CD) spectra (185 to 260 nm) were
recorded with a Jasco J-810 spectropolarimeter at 20°C using 20 mM
sodium phosphate (pH 7) and a 1-mm-path-length quartz Suprasil cell
(Hellma), with protein concentrations of ca. 0.06 to 0.1mg/ml. Data from
four scans (10 nm/min, 1-nm bandwidth, 0.2-nm data pitch, and 1-s data
integration time [DIT]) were averaged, baselines were subtracted, and no
smoothing was applied. Data are presented as the residue ellipticity
([]MRW) (MRW, mean residue weight) calculated using the molar con-
centration of protein and number of residues.
Secondary-structure analyses using theCDSSTR (22, 23), CONTINLL
(24, 25), and SELCON3 (26, 27) algorithms were performed on the CD
datawith theDichroweb analysis server (28, 29), using both reference data
sets 3 and 6. The results from the three algorithms were averaged, and the
standard deviations of the results of comparisons of the calculated sec-
ondary structures are given in Results (Table 2). The accuracy of the anal-
ysis was checked using the goodness-of-fit parameter (normalized
root mean square deviation [NRMSD]) values. With both CDSSTR
and CONTINLL, NRMSD values below 0.1 indicated a good correspon-
dence between the calculated secondary-structure data and the experi-
mental CD data. In contrast, SELCON3 yielded higher NRMSD values
(ranging between 0.09 and 0.16); nevertheless, the data obtained with this
algorithm and with the other two were identical within the error limit.
TABLE 1 Oligonucleotides used for site-directed mutagenesis and
sequencing









a The mutated positions are underlined. The restriction site sequences are in bold.




Helices (%) Strands (%) Turns (%) Unordered (%)
NDM-1 wta 33 2 17 1 20 2 30 2
NDM-1 I35S 19 1 32 7 21 0.4 28 6
NDM-1 I35T 11 2 34 3 21 2 34 3
a wt, wild type.
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Molecularmodeling.The X-ray structure of NDM-1 in complex with
cephalexin (PDB code 4RL2) (30) was used for the initial positioning of
loracarbef in the active site of NDM-1 before proceeding with a standard
energy minimization protocol with the program YASARA (31). This pro-
tocol consists of steepest-descent minimization followed by simulated
annealing of the ligand and protein side chains. Simulation parameters
consist of the use of a Yasara2 force field (32), a cutoff distance of 7.86 Å,
particle mesh Ewald (PME) long-range electrostatics (33), periodic
boundary conditions, and a water-filled simulation cell.
RESULTS
NDM-1I35T and NDM-1I35S mutants were obtained by site-di-
rectedmutagenesis by using NDM-1 as the template. The NDM-1
enzyme is unstable when it is produced with its native signal pep-
tide (34). For this reason, blaNDM-1, blaNDM-1
I35T, and blaNDM-1
I35S
genes were cloned into pET-24(a) vector without signal peptide
for protein expression and purification. The wild-type and
mutant enzymes were purified from E. coli JM109(DE3)/pFM-
NDM-1, E. coli JM109(DE3)/pFM-NDM-1I35T, and E. coli
JM109(DE3)/pFM-NDM-1I35S by two chromatographic steps
which yielded the enzyme as more than 95% pure, as evaluated by
SDS-PAGE analysis.
Before starting with analysis of the kinetic parameters, analysis
of the stability of enzymes NDM-1, NDM-1I35T, and NDM-1I35S
was performed by incubating the enzymes at 30°C, 40°C, and 50°C
for up to 120 min in buffer C (without zinc ions). At 30°C and
40°C, all three enzymes followed the same trend, and their residual
activity after 120 min of incubation was about 60%. Indeed at
50°C, NDM-1 and NDM-1I35T showed, after 120 min of incuba-
tion, 20% and 30% residual activity, respectively. In contrast,
NDM-1I35S showed a residual activity level of approximately 50%
under the same conditions (Fig. 1). The experiments were repli-
cated but using a buffer C with the addition of 20 M ZnCl2. At
30°C, 40°C, and 50°C, after 120 min of incubation, the residual
activity seen with all three enzymes ranged between 90% and
100% (data not shown). Therefore, the three enzymes were in all
cases stable in the presence of zinc.
The conformations of the NDM-1, NDM-1I35T, and NDM-
1I35S enzymes were studied by analysis of fluorescence spectra us-
ing a 200 nM concentration of each enzyme. The most intense
fluorescence peaks were at about 345 nm, but the three enzymes
showed different levels of fluorescence intensity (data not shown).
The arbitrary fluorescence unit values determined for NDM-1,
NDM-1I35T, andNDM-1I35S were about 240, 140, and 296, respec-
tively. The secondary-structure contentwas studied by far-UVCD
spectra (Fig. 2) and analyzed by using three different algorithms.
The levels of helical content calculated from these spectra were
33%  2% for NDM-1, 19%  1% for NDM-1I35S, and 11% 
2% for NDM-1I35T (Table 2). Comparing with NDM-1, the
NDM-1I35S and NDM-1I35T mutants showed 10% and 20% re-
ductions in -helix content, respectively.
The effect of the zinc ion was assessed by spectrophotometric
assay using 100M imipenem as the substrate and ZnCl2 concen-
trations ranging from 0 to 100 M. As shown in Table 3, an in-
crease in specific activity was observed in NDM-1 andNDM-1I35T
FIG 1 Thermal stability of NDM-1mutants in comparison with that of the NDM-1 enzyme at 50°C. Data are mean values of the results of three measurements.
The standard deviation was always lower than 10%. The experiments were performed as described in the text. WT, wild type.
FIG 2 Far-UV CD spectra of the NDM-1 wild-type strain and the NDM-1I35S
andNDM-1I35Tmutants. Data were obtained at 20°C using 20mMphosphate
buffer, with protein concentrations of ca. 2 to 4 M.
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at 20MZnCl2, but addition of Zn
	2 at higher concentrations did
not affect the activity versus that seen with imipenem. In contrast,
the addition of ZnCl2 did not alter the imipenem hydrolysis in the
NDM-1I35S mutant. On the basis of these results, a concentration
of 20 M ZnCl2 was used for kinetic assays.
TheNDM-1,NDM-1I35T, andNDM-1I35S enzymeswere tested
versus 16-lactam substrates that were all hydrolyzed by the three
enzymes with the exception of aztreonam (Table 4). Benzylpeni-
cillin and carbenicillin are good substrates for the three enzymes,
with similar Km and kcat values, with the exception of kcat for
NDM-1I35T, where the values are reduced by 50%. Even when the
kcat values calculated for imipenem and biapenem for NDM-1
I35S
were higher than those calculated for NDM-1 and NDM-1I35T,
their catalytic efficiencies were similar. The Km of NDM-1
I35S
for biapenem was 1,000 M, about 10-fold higher than that
of NDM-1. Regarding meropenem, the catalytic efficiencies of
NDM-1I35T and NDM-1I35S mutants were lower than that of
NDM-1. This is due to the low kcat values of the mutants in com-
parison to the wild-type enzyme.
The NDM-1, NDM-1I35T, and NDM-1I35S enzymes were probed
against first-, second-, third-, and fourth-generation cephalospo-
rins. Compared with NDM-1, the mutant enzymes showed a de-
crease of kcat and kcat/Km values for cefazolin. In the case of second-
generation cephalosporins, different results were observed for
cephamycin (cefoxitin), carbacephems (cefaclor and loracarbef),
and oxacephem (moxalactam). The kcat values forNDM-1,NDM-
1I35T, andNDM-1I35S for cefoxitin were 23 s1, 11 s1, and 44 s1,
respectively, but the catalytic efficiency values are similar. Toward
cefaclor and moxalactam, the three enzymes showed the same
behavior: a reduction of kcat and kcat/Km values was observed. In-
terestingly, the NDM-1I35S mutant showed a kcat/Km value versus
loracarbef about 14-fold higher than that of NDM-1. A significant
reduction of the Km value in NDM-1
I35S with respect to the wild
type was also observed. The fourth-generation cephalosporin
tested, cefepime, was less hydrolyzed by the mutants than by
NDM-1. Aztreonam was not hydrolyzed by the three enzymes.
Sulbactam, a serine--lactamase inhibitor, waswell hydrolyzed by
the three enzymes but with high (
1,000 M) Km values.
In vitro susceptibility to various -lactams was investigated
for E. coli JM109(DE3)/pSP-NDM-1, E. coli JM109(DE3)/
pSP-NDM-1I35S, and E. coli JM109(DE3)/pSP-NDM-1I35T in
comparison with the E. coli JM109(DE3)/pET-24(a) recipient.
Results of these experiments showed that production of the
NDM-1, NDM-1I35T, and NDM-1I35S enzymes was readily able to
confer resistance to all of the-lactams used with the exception of
aztreonam (Table 5).
DISCUSSION
NDM-1 metallo--lactamase is an extended-spectrum enzyme
with an ability to hydrolyze most -lactams, with the exception of
monobactams. Unlike such other subclass B1 examples as IMP
and VIM enzymes, NDM-1 has a long N terminus forming two
extra strands designated 1= and 1 (13). In addition, NDM-1
has a wider L3 loop. This flexible loop is present in most subclass
B1 MBLs, and it is involved in substrate binding and specificity
(13). In contrast to IMP and VIM variants, in NDM-1 enzyme an
isoleucine residue at position 35 connects the two extra -strands
positioned at the N terminus of the enzyme. Isoleucine 35 is at the
tip of the 1 strand, and it is oriented toward the active site and
seems to be correlated with substrate binding and the hydropho-
bicity of the L3 loop (13). In the present study, two NDM-1 labo-
ratorymutants, obtained by replacing the isoleucine at position 35
(I35) with a serine (NDM-1I35S mutant) or a threonine (NDM-
1I35Tmutant), were generated to elucidate the role of isoleucine in
the structure, substrate binding, and hydrophobicity of the en-
TABLE 3 Initial rates of hydrolysis for NDM-1, NDM-1I35T, and NDM-




0 M Zn2	 20 M Zn2	 50 M Zn2	 100 M Zn2	
NDM-1 59 130 134 130
NDM-1I35T 27 80 70 70
NDM-1I35S 99 99 107 103
a Rates of hydrolysis (v0) are expressed in millimoles per milligram of imipenem (100
M) hydrolyzed per minute per milligram of enzyme.
TABLE 4 Kinetic parameters of the NDM-1, NDM-1I35T, and NDM-1I35S enzymes for some -lactams
Substrate
NDM-1 NDM-1I35T NDM-1I35S
Km (M) kcat (s
1) kcat/Km (M s
1) Km (M) kcat (s
1) kcat/Km (M s
1) Km (M) kcat (s
1) kcat/Km (M s
1)
Benzylpenicillin 250 10 105 0.42 250 10 58 0.23 380 23 130 0.34
Carbenicillin 285 5 108 0.38 650 36 62 0.09 680 30 163 0.24
Imipenem 35 1 64 1.83 42 3 24.5 0.58 90 6 107 1.19
Meropenem 80 2 75 0.94 90 5 27 0.30 60 4 35 0.58
Biapenem 120 4 30 0.25 300 8 19 0.06 1,000 40 141 0.14
Cefazolin 20 1 42 2.10 14 2 12 0.86 21 3 28 0.90
Cefoxitin 26 1 23 0.88 18 1 11 0.61 65 4 44 0.68
Cefaclor 30 2 31 1.03 35 3 12 0.34 14 1 6 0.43
Loracarbef 40 2 42 1.05 9 1 30 3.33 4 0.5 56 14.0
Moxalactam 22 1 15 0.68 50 7 7 0.14 60 5 17 0.28
Cefotaxime 14 1 20 1.43 8 3 5 0.63 3 0.3 11 3.67
Ceftazidime 50 4 18.5 0.37 44 5 6 0.14 40 2 11 0.28
Cefepime 35 5 13 0.37 40 3 6 0.15 32 1 6 0.19
Aztreonam NHa NH NH NH NH NH NH NH NH
Sulbactam 1,400 50 50 0.036 1,100 45 19 0.017 1,300 32 66 0.05
Nitrocefin 15 3 10 0.67 21 4 6 0.29 20 2 7 0.35
a NH, not hydrolyzed.
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zyme. To date, experimental studies regarding this residue in
NDM-1 have not been available. The wild type and the mutants
were overexpressed and purifiedwithout signal peptide because of
their instability, as previously reported by Kim and coworkers
(34). The temperature stabilities of the three enzymes at 30°C and
40°C were similar. However, when the enzymes were incubated at
50°C the NDM-1I35S mutant was more stable than the wild-type
and NDM-1I35T enzymes. Fluorescence assays showed changes in
the intensities of the spectra among the three enzymes (data not
shown) even if any shift in the maximum emission wavelength
(lambda max) was observed in the mutants. The absence of
change in the lambda max indicates that the exposure of trypto-
phan residues to solvent does not change in the mutants. This
means that the overall three-dimensional (3D) structure was un-
changed. Combined with far-UV CD data, this suggests that con-
formational changes are restricted to the local conformation of the
backbone (i.e., the secondary structure) and do not perturb sig-
nificantly the 3D structure.
Kinetic data on NDM-1I35T and NDM-1I35S show that, even
though a hydrophobic residue such as isoleucine was replaced by
two polar residues (serine and threonine), the enzymes main-
tained high catalytic efficiencies. The I35 is packed against the L3
loop and is located in the proximity of the substrate binding site
(13). It is only 5.2 Å away from the two methyl groups bound on
the C6 carbon of ampicillin in the NDM-1–ampicillin complex
structure (PDB code 3Q6X) (data not shown). Despite the intro-
duction of polar residues, differences between the two mutants in
the activities directed toward the substrates tested were observed.
In particular, in comparison to NDM-1, NDM-1I35T exhibited
lower kcat and catalytic efficiencies toward all -lactams tested
with the exception of loracarbef. This decrease of enzyme activity
could be due to a different orientation of the threonine versus the
FIG 3 Molecular modeling of the NDM-1 in complex with hydrolyzed loracarbef. (A) NDM-1 in complex with loracarbef. (B) Overview of loop L3 focused on
residue Ile-35. The distance between Ile-35 and loracarbef is shown as a red dashed line.
TABLE 5 Patterns of -lactam resistance mediated by NDM-1, NDM-1I35S, and NDM-1I35T in E. coli JM109(DE3) in comparison with the pattern



















Biapenem 16 16 64 0.125
Cefazolin 256 128 256 0.0625
Cefotaxime 128 32 64 0.0625
Ceftazidime 256 128 256 0.0625
Cefoxitin 8 16 32 0.125
Cefepime 32 16 32 0.0625
Loracarbef 128 128 128 0.0625
Cefaclor 64 64 128 0.5
Moxalactam 64 32 64 0.125
Benzylpenicillin 512 256 
512 0.5
Carbenicillin 512 256 
512 0.5
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active site because of its less bulky side chain compared to isoleu-
cine. Nevertheless, the substitution of the I35 into a threonine
results in retention of most of the shape. Compared to NDM-
1I35T, the mutation of I35 into a serine adds some flexibility to the
L3 loop. The introduction of a serine residue at this positionmain-
tains the catalytic efficiencies for all -lactams tested, except lo-
racarbef. For loracarbef, the kcat/Km value is 14-fold higher than
that of NDM-1. The increase of catalytic efficiency is due to the
lower Km value (4M) compared to NDM-1 (Km 40M). The
serine residue seems to react better with loracarbef. This is likely
due to the proximity of the chlorine atom of this substrate and the
hydroxyl group of the serine (Fig. 3), leading to the potential for-
mation of a hydrogen bond during substrate hydrolysis responsi-
ble for the higher affinity observed. Interestingly, NDM-1 showed
similar levels of behavior in terms of Km, kcat, and kcat/Km toward
loracarbef and cefaclor, two second-generation cephalosporins
with the sameR1 andR2 groups (data not shown). In contrast, the
introduction of polar residues changes the kcat/Km values of mu-
tants versus loracarbef only and not versus cefaclor. The slightly
differences of conformation among the six-member rings of lo-
racarbef and cefaclor therefore seem sufficient to prevent an effi-
cient interaction during cefaclor hydrolysis. The catalytic effi-
ciency of NDM-1I35S toward biapenem is only slightly lower than
that of the wild-type enzyme. It is, however, the result of an 8-fold
Km increase compensated by a 4-fold kcat increase. This behavior
could be due to the reduced compatibility between the bulky and
rigid charged side chain of biapenem and the more flexible and
polar side chain of a serine at position 35. In conclusion,mutation
at position 35 induces some structural changes, which can be as-
signed to a 10% to 20% loss of -helical structure. The I35 is
important for the enzyme structure but not for substrate binding
and catalysis. However, the mutants remain folded and well orga-
nized but the secondary-structuremodification that occurs locally
at the site of the mutation seems to influence the activity against
only some substrates (biapenem and loracarbef).
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